Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.
Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs
Sai Priya Nimmagadda, Nethra Somannagari, Shubham G, Saumya LG, Venu Bolisetti, Srikanth Gadam
Background: Since the World Health Organisation has declared COVID-19 a pandemic on 11 March 2020, it has become a significant health concern at an alarming rate. There have been tremendous efforts by the countries to provide adequate care to the people affected by SARS-CoV-2. India is running one of the worldʼs largest vaccination programmes.COVID-19 vaccines are designed to prompt an immune response that, recognises and blocks the virus .However people with comorbidities who have a weakened immune response may still be at risk even after vaccination.
Aim: The aim of our study is to assess clinical pattern of disease among vaccinated COVID-19 patients and to find the correlation between comorbdities and the severity of disease outcome in post vaccinated COVID-19 patients.
Materials and method: A descriptive cross sectional study was done taking COVID-19 patients from GANDHI Hospital, Secunderabad admitted during the months of May to August 2021.Gandhi Hospital is a territory care facility which has been the heart of pandemic management. On a random basis 1000 COVID-19 patients were taken, out of which 99 were vaccinated either with single or both doses. The data was collected via telecommunication using a semi structural standardised pro forma and the responses were noted. The data was entered in a MS Excel sheet and analysed using IBM SPSS statistics.
Results: In our study the association between comorbidity and outcome was found to be statistically significant (p=0.028).Out of the 61 patients with comorbidities 35(57.4%) fully recovered, 16(26.2%) partially recovered and 10(16.4%) died. We have found that post vaccinated COVID-19 patients with comorbidities have longer hospital stay probability (61.6%) and oxygen requirement (65.6%).
Conclusion: Our study showed that among the breakthrough infections, the risk of mortality is approximately 8 times more in patients with comorbidities. This shows that COVID-19 is still possible even after vaccination are hitting people with one or more comorbidities particularly hard.